The AACR–Male Breast Cancer Global Alliance–Daryl and Christine Soneral Innovation and Discovery Grant for Male Breast Cancer Research 2027 provides $50,000 for one year to independent investigators worldwide.
The grant supports innovative basic, translational or clinical research addressing unmet needs in male breast cancer. Projects may investigate disease mechanisms, therapeutic targets, biomarkers, treatment response or resistance, and precision medicine. Research focused on metastatic male breast cancer receives preference.
Eligibility Criteria
- Applicants must hold a PhD, MD, MD/PhD or equivalent doctoral degree by July 1, 2027.
- Applicants must be independent, non-mentored investigators.
- Applicants must work at an academic, medical or research institution.
- Researchers worldwide may apply, with no citizenship restrictions.
- Applicants must meet AACR’s Active Membership requirements by the submission deadline.
- Applicants cannot be pursuing another doctoral degree at the start of the award.
- Employees or subcontractors of US federal government entities or for-profit industry cannot receive funding as applicants.
- Recipients cannot hold another AACR grant concurrently.
Funding Details
- Award amount: $50,000 USD.
- Duration: One year.
- Start date: July 1, 2027.
- Supports hypothesis-driven research directly relevant to male breast cancer.
- Extensive replication of established research without substantial innovation is outside the program’s scope.
Deadline
- Full application: January 12, 2027, at 1:00 p.m. US Eastern Time.
- Award notification: June 2027.
Further Information
Read “Pfizer Atirmociclib Breast Cancer Research Grants 2027: $8 Million Funding Pool” on OncoGrants By OncoDaily.